科研速递论坛

标题: A 24-week, parallel-group, open-label [打印本页]

作者: wrh 时间: 2013-11-6 18:43
标题: A 24-week, parallel-group, open-label

题名	A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
作者	Zheng MH, Shi KQ, Dai ZJ, Ye C, Chen YP.
杂志	Clin Ther
年\|卷\|期	. 2010 Apr;32(4):649-58. doi: 10.1016/j.clinthera.2010.04.001.
页码	649-58. doi
链接	http://www.ncbi.nlm.nih.gov/pubmed/20435234

作者: jocktor 时间: 2013-11-6 18:43
http://dl.vmall.com/c03wl033ta

作者: jocktor 时间: 2013-11-6 18:47
1111111111111

作者: sying5 时间: 2013-11-6 18:48
11111111111

作者: sying5 时间: 2013-11-6 18:50
http://1000eb.com/qumr

作者: lo7ve77 时间: 2013-11-9 00:42
请及时选择最佳答案，谢谢配合！

欢迎光临科研速递论坛 (http://expaper.cn/)